ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
06 Mar 2024

The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today

The exercise period for the warrants of series 2024:U1 (TO2) (the "Warrants") issued in connection with Acarix AB ("Acarix" or the "Com...
Continue reading
author-avatar acarix
Press
August 6, 2024
06 Mar 2024

The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today

The exercise period for the warrants of series 2024:U1 (TO2) (the "Warrants") issued in connection with Acarix AB ("Acar...
Continue reading
author-avatar acarix
Press
August 6, 2024
21 Feb 2024

Kommuniké från extra bolagsstämma i Acarix

Extra bolagsstämma i Acarix AB ("Bolaget") hölls idag den 21 februari 2024 varvid aktieägarna fattade följande beslut. Godkän...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
21 Feb 2024

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB (the "Company") was held today on 21 February 2024 and the following resolution was passed by th...
Continue reading
author-avatar acarix
0 comments
Press
February 21, 2024
21 Feb 2024

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB (the "Company") was held today on 21 February 2024 and the following resolution was pa...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
21 Feb 2024

Kommuniké från extra bolagsstämma i Acarix

Extra bolagsstämma i Acarix AB ("Bolaget") hölls idag den 21 februari 2024 varvid aktieägarna fattade följande besl...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Feb 2024

Acarix strengthens US Advisory Board with three industry leaders

New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of t...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
15 Feb 2024

Acarix expanderar USA-baserat Advisory Board med tre nya rådgivare

New York, New York, 15 februari 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, har utnämnt ...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Feb 2024

Acarix expanderar USA-baserat Advisory Board med tre nya rådgivare

New York, New York, 15 februari 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, har utnämnt tre nya rådgivar...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
15 Feb 2024

Acarix strengthens US Advisory Board with three industry leaders

New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointmen...
Continue reading
author-avatar acarix
Interim, IR, Listing Regulation, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
15 Feb 2024

Acarix AB (publ) publicerar Bokslutskommuniké 2023

Fokus mot USA och hållbar tillväxtSom nyutnämnd VD är jag hedrad att få leda Acarix och dela en del av v&ari...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Feb 2024

Acarix AB (publ) publishes Year-End Report 2023

Embarking on a new journey with focus on sustainable growth As the newly appointed CEO of Acarix, I am honored to be on board and share...
Continue reading
  • «
  • ‹
  • 11
  • 12
  • 13
  • 14
  • 15
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.